- Home
- BOLT vs MTNB Comparison
BOLT vs MTNB Comparison
Compare BOLT & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- MTNB
- Stock Information
- Founded
- BOLT 2015
- MTNB 2013
- Country
- BOLT United States
- MTNB United States
- Employees
- BOLT N/A
- MTNB N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- BOLT Health Care
- MTNB Health Care
- Exchange
- BOLT Nasdaq
- MTNB Nasdaq
- Market Cap
- BOLT 9.4M
- MTNB 7.9M
- IPO Year
- BOLT 2021
- MTNB N/A
- Fundamental
- Price
- BOLT $5.19
- MTNB $1.68
- Analyst Decision
- BOLT Buy
- MTNB Hold
- Analyst Count
- BOLT 3
- MTNB 1
- Target Price
- BOLT $47.50
- MTNB N/A
- AVG Volume (30 Days)
- BOLT 14.4K
- MTNB 1.4M
- Earning Date
- BOLT 08-14-2025
- MTNB 08-14-2025
- Dividend Yield
- BOLT N/A
- MTNB N/A
- EPS Growth
- BOLT N/A
- MTNB N/A
- EPS
- BOLT N/A
- MTNB N/A
- Revenue
- BOLT $4,167,000.00
- MTNB N/A
- Revenue This Year
- BOLT N/A
- MTNB N/A
- Revenue Next Year
- BOLT N/A
- MTNB N/A
- P/E Ratio
- BOLT N/A
- MTNB N/A
- Revenue Growth
- BOLT N/A
- MTNB N/A
- 52 Week Low
- BOLT $4.59
- MTNB $0.47
- 52 Week High
- BOLT $14.36
- MTNB $4.25
- Technical
- Relative Strength Index (RSI)
- BOLT 46.64
- MTNB 52.06
- Support Level
- BOLT $4.81
- MTNB $1.64
- Resistance Level
- BOLT $5.28
- MTNB $1.90
- Average True Range (ATR)
- BOLT 0.26
- MTNB 0.24
- MACD
- BOLT 0.01
- MTNB -0.05
- Stochastic Oscillator
- BOLT 70.26
- MTNB 38.38
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.